Logo

Mandar Kulkarni

May 22, 2015

Cancer Genetics has appointed Mandar Kulkarni chief technology officer of Cancer Genetics, India. Kulkarni will direct efforts at expanding CG India's technology programs and initiatives with a focus on accelerating development and innovation. He will report to Cancer Genetics CEO Panna Sharma. Kulkarni joins the company from Sandor Lifesciences where he was head of molecular biology and genomics. He was also a senior scientist at M/Z Diagnostics.

Breaking News
The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.